Renowned industry expert Albert Pattison kick started the company in 2002 with a core mission to manufacture and supply the Manchester Capillary Reagent.
The Manchester Capillary Reagent is the first-choice solution for INR monitoring and a corner stone of our business.
In 2009, we relocated to our purpose-built headquarters at the Rivergreen Business Centre in Hartlepool. This move provided modern office space and advanced laboratory facilities, supporting continued growth and innovation in haemostasis testing and platelet function diagnostics.
Our Platelet Aggregation work was a shrewd business move for Hart Bio. It filled a gap in the market and enabled us to work with industry experts to create a full suite of testing capabilities for whole blood and plasma samples, putting us ahead of the competition.
We secured an exclusive distribution partnership with leading German medical diagnostics supplier Haemochrom Diagnostica.
The contract allows us to supply its platelet function and platelet aggregation reagent lines into several European countries.
We bagged a double honour, winning in both the Export and Innovation awards at the North East Business Awards in 2015.
We were the only organisation lucky enough to collect two trophies on the night.
We represented the UK at the International Society of Thrombosis, where we were joined by distinguished companies from more than 300 medical societies and government health agencies from 65 countries.
The conference called for hospital-based risk assessments for venous thromboembolism (VTE).
We've since moved this to a regular occurrence, aiming to attend each of the (now annual) ISTH events.
In 2017, Hart Biologicals enjoyed a multi award-winning year, receiving honours at both the North East Business Awards and the Made in the North East Awards. These accolades highlighted our ongoing commitment to excellence and innovation in the biomedical sector.
We’re seen as a pillar of the community in the region and in 2017 our founder Alby Pattison was awarded the Freedom of Hartlepool for services to the local community.
Alby received his MBE for services to international trade and the Tees Valley economy.
He received the award at a glittering ceremony at Buckingham Palace accompanied by his wife and family.
In 2018 we opened our 6th bespoke, humidity-controlled production lab. This gave us even more capacity and agility to support our expanding customer base.
All our facilities help our team to develop and control our products and processes with utmost precision.
In 2019, Alexander Ebinger succeeded founder Alby Pattison as Managing Director. Having joined in 2013 and served as Head of Research and Development, Alex played a key role in shaping the company’s global strategy. Under his leadership, Hart Biologicals continues to build on a strong legacy of quality, growth, and innovation in diagnostic instrumentation.
Since our small beginning, we’ve grown and developed year on year, expanding our expertise and resources.
Today, our laboratories are equipped with state-of-the-art diagnostic equipment, including three fully automated bespoke freeze-driers, dedicated pellet production facilities, and advanced bioburden testing systems. Alongside a comprehensive documentation archive, these capabilities position us at the forefront of the biomedical industry, delivering trusted solutions to laboratories worldwide.
With over 10 years experience in Haemostasis R&D, Alex is dedicated to keeping Hart Biologicals at the top of its field scientifically and growing the business through technological advancement.
With over 12 years’ service at Hart, Keighley has extensive technical knowledge and product expertise, understanding our customers’ needs and business values. She oversees technical requirements and validation processes of Hart and client products.
With a background in computational biochemistry, Jack overseeins the distributor network, marketing activities, and strategy at Hart.
Jason oversees production at Hart, and is also the problem solver, linking up with external contractors and companies to improve infrastructure within the company.
With classical education in biochemistry from Tübingen (Germany), Christian is Hart's R&D lead, working on development of new reagents, techniques, and products from within the company.
Jenny is the go-to person for quality and regulatory affairs. She explores requirements for doing business in new regions, and also contributes a lot to our internal quality system.
Nicole is our product manager, linking departments together to handle the needs of our external partners. She works to ensure a smooth connection between supplier and customer.
After graduating with a degree in Biomedical Science, John has worked in Hart’s Quality Control Department since 2012.
Sandra is a former NHS Rheumatology nurse, now focusing on forming strategic partnerships to coordinate Hart's blood requirements throughout all departments.
Richie started at Hart in R&D -- now he's the Technical department's supervisor, helping to oversee technical documentation; implementing and validating new products, and assisting with all other technical enquiries.
Having worked her way up from starting at Hart as an apprentice, Kensey is now our production supervisor, in charge of handling scheduling, staffing, and ensuring that Hart produces high-quality products, week-in, week-out.